CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Ranibizumab 0.3 mg - 3 times monthly, then quarterly - Phase 3 | NVS Pipeline | CatalystAlert